Global Specialty Enzymes Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (Oxidase, Nucleases, Restriction Enzymes, Polymerases, Lipases, Amylases, Others), By Source (Micro-Organisms, Plants, Animals), By Application (Pharmaceuticals, Research & Biotechnology, Diagnostic, Bio-Catalyst), And By Geography - Forecasts From 2022 To 2027

  • Published : Mar 2022
  • Report Code : KSI061611066
  • Pages : 124

The global specialty enzymes market is expected to grow at a compound annual growth rate of 9.08% over the forecast period to reach a market size of US$5.144 billion in 2027 up from US$2.280 billion in 2020.


Enzymes are biocatalyst proteins. Enzymes bind to and function as substratum for molecules. The conversion of the substrates into distinct molecules occurs using an enzyme known as a product.  The reaction rate is improved by the use of the catalyst. A biocatalyst is a micro-organism-generated enzyme that is environmentally friendly. The enzymes, in particular, differ from traditional enzymes. Specialty enzymes are the new technology used mostly for the development of new foods.  Different industries are also used specialty enzymes. Enzymes such as proteases, lipases, glycosides, hydrolipases, transglutaminases, and many more have been altered. Develops novel enzyme features such as thermal stability and enhances enzyme activity at low temperatures. The main technologies utilized for developing specialty enzymes are recombinant DNA technology, genetic engineering, and protein engineering. Specific incidents of death, such as cardiovascular diseases, oncogenes, asthma, lysosomal diseases, and pain throughout older age are also analyzed using special enzymes. Also employed for the alteration of DNA are specialty enzymes. Polymerase and nucleases are specialized enzymes used in biology, pharmaceutical industries, and diagnostics.  Special enzymes are probiotics used to more efficiently convert food to energy. In tissue replacement and generating new tissue in the body, specialty enzymes are also employed.  Due to urbanization and a change in customer choice, specialty enzymes have increased demand in recent years and added favorable market feelings.

Market Trends

The need for specialty enzymes in the global market has increased with changes in metabolism and the increase in the aging population. According to data from the World Bank, the share of the population aged 65 years and above in the total population has increased from 7.57% in 2010 to 9.32% in 2020. The elderly population aged 65 years and above has grown from 523.576 billion in 2010 to 723.184 billion in 2020, growing by more than 38% during the decade. The world market for specialty enzymes is predicted to rise due to developments in biotechnology and research institutes,  the pharmaceutical sector, and expansion in the diagnostic sector with the development of green chemistry. Specialty enzymes on the market have increased demand for them due to new technology innovations and trend changes compared to standard enzymes. 

However, the market for customized enzymes is mainly concerned with food sensitivities, intolerances, and pH-maintained at operating temperatures. Biotech innovation and the low consumption of chemical enzymes are the main reasons driving the worldwide specialty enzyme market in new diagnostic techniques. Consumers' lack of awareness of the benefits of specific enzymes is also a worldwide market threat.

Growth Factor

  • Increasing healthcare spending

An increase in healthcare expenditures has also led to the increased usage of tailored medicines, hence increasing the use of diagnostic tests and genetic sequences. This creates a considerable need for diagnostic testing for specialized enzymes. High competition in the pharmaceutical industry is predicted to significantly boost the global need for customized enzymes throughout the forecast.  More investment is also planned to promote the use of specialty enzymes in research and biotechnology during the predicted period in the pharmaceutical industry,  for developing new biological pharmaceuticals. In addition, pharmaceutical companies are using biocatalysts more to lower pharmaceutical costs and manufacture cost-effective non-generic medications, another factor that is projected to drive expansion in the worldwide enzyme market. The increased use of specialist enzymes for diseases such as lysosomal disorders, cardiovascular diseases, and cancer therapy also fuels the demand for specialty enzymes.

COVID-19's Influence 

The COVID-19 pandemic, however, is expected to act as a restraint to this market’s growth considering the disruptions in supply chains and business operations of market players caused by the lockdowns imposed because of the pandemic.

Competitive Insights

The increasing global demand for coupled inductors has led to the entry of several new players in the global specialty enzymes market. Major market players like Johnson & Johnson Medical Devices, Aesculap, Inc., and Medtronic, among others, have been covered along with their relative competitive strategies.

Global Specialty Enzymes Market Scope:


Report Metric Details
 Market Size Value in 2020  US$2.280 billion
 Market Size Value in 2027  US$5.144 billion
 Growth Rate  CAGR of 9.08% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Billion
 Segments Covered  Type, Source, Application, And Geography
 Regions Covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies Covered Amano Enzyme Inc., BASF SE, Codexis, Sanofi, Novozymes A/S, Nagase & Co. Ltd., Biocatalysts, Kerry Inc., DuPont de Nemours, Inc., Specialty Enzymes & Probiotics
 Customization Scope  Free report customization with purchase


Market Segmentation:

  • By Type
    • Oxidase
    • Nucleases
    • Restriction Enzymes
    • Polymerases
    • Lipases
    • Amylases
    • Others
  • By Source
    • Micro-organisms
    • Plants
    • Animals
  • By Application
    • Pharmaceuticals
    • Research & Biotechnology
    • Diagnostic
    • Bio-Catalyst
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • Italy
      • Spain
      • Others
    • Middle East and Africa
      • Israel
      • Saudi Arabia
      • Others
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others

Frequently Asked Questions (FAQs)

The global specialty enzymes market is expected to reach a total market size of US$5.144 billion in 2027.
The specialty enzymes market is expected to grow at a CAGR of 9.08% during the forecast period.
Specialty Enzymes Market was valued at US$2.280 billion in 2020.
The global specialty enzymes market has been segmented by type, source, application, and geography.
High competition in the pharmaceutical industry is predicted to significantly boost the global specialty enzymes market.
1. Introduction
1.1. Market Definition
1.2. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Function
4.4. Function Value Chain Analysis

5. Global Specialty Enzymes Market Analysis, By Type
5.1. Introduction
5.2. Oxidase
5.3. Nucleases
5.4. Restriction Enzymes
5.5. Polymerases
5.6. Lipases
5.7. Amylases
5.8. Others

6. Global Specialty Enzymes Market, By Source
6.1. Introduction
6.2. Micro-organisms
6.3. Plants
6.4. Animals

7. Global Specialty Enzymes Market, By Application
7.1. Introduction
7.2. Pharmaceuticals
7.3. Research & Biotechnology
7.4. Diagnostic
7.5. Bio-Catalyst 

8. Global Specialty Enzymes Market, By Geography  
8.1. Introduction
8.2. North America  
8.2.1.  United States
8.2.2.  Canada
8.2.3.  Mexico
8.3. South America  
8.3.1.  Brazil
8.3.2.  Argentina
8.3.3.  Others
8.4. Europe  
8.4.1.  UK
8.4.2.  Germany
8.4.3.  Italy
8.4.4.  Spain
8.4.5.  Others
8.5. The Middle East and Africa  
8.5.1.  Israel 
8.5.2.  Saudi Arabia
8.5.3.  Others
8.6. Asia Pacific  
8.6.1.  China
8.6.2.  Japan
8.6.3.  India
8.6.4.  Australia
8.6.5.  South Korea
8.6.6.  Taiwan
8.6.7.  Thailand
8.6.8.  Indonesia
8.6.9.  Others

9.  Competitive Environment and Analysis
9.1.  Major Players and Strategy Analysis
9.2.  Emerging Players and Market Lucrativeness
9.3.  Mergers, Acquisitions, Agreements, and Collaborations
9.4.  Vendor Competitiveness Matrix

10.  Company Profiles.
10.1. Amano Enzyme Inc.
10.2. BASF SE
10.3. Codexis
10.4. Sanofi
10.5. Novozymes A/S
10.6. Nagase & Co. Ltd.
10.7. Biocatalysts
10.8. Kerry Inc.
10.9. DuPont de Nemours, Inc.
10.10. Specialty Enzymes & Probiotics

Amano Enzyme Inc.




Novozymes A/S

Nagase & Co. Ltd.


Kerry Inc.

DuPont de Nemours, Inc.

Specialty Enzymes & Probiotics